In the News


Task Force draft recommendation leaves PSA screening choice up to patients

Clinicians should talk to men ages 55 to 69 about the potential benefits and harms of screening, according to the U.S. Preventive Services Task Force. For men ages 70 years and older, the potential benefits of prostate-specific antigen (PSA)-based screening do not outweigh the harms, the Task Force said.

New persistent opioid use after elective surgery similar between minor, major procedures

Researchers used administrative health claims from Jan. 1, 2012, to June 30, 2015, among a cohort of privately insured adults ages 18 to 64 years who had surgery between 2013 and 2014.

MKSAP quiz: Evaluation for recurrent nephrolithiasis

This week's quiz asks readers to determine the most appropriate additional treatment for a 28-year-old man with recurrent nephrolithiasis.

Short-term oral corticosteroid use common, but may pose risks

Researchers conducted a retrospective cohort study and self-controlled case series to determine the frequency of prescriptions for less than 30 days of oral corticosteroids and any association with adverse events.

ACP Leadership Academy offers webinar series on improving patient outcomes through QI

The first webinar in the series will discuss “Leading Practice Transformation and Quality Improvement in Times of Change.”

MKSAP celebrates 50th birthday with a video

2017 marks the 50th anniversary of ACP's Medical Knowledge Self-Assessment Program® (MKSAP®), ACP's trusted educational resource.

Put words in our mouth

ACP Internist Weekly wants readers to create captions for our new cartoon and help choose the winner. Pen the winning caption and win a $50 gift certificate good toward any ACP product, program, or service.

Physician editor: Philip Masters, MD, FACP